Belgium· BE-AMP-SAM236941-00

Valcyte 450 mg

A valganciclovir product containing valganciclovir hydrochloride, registered in Belgium by Cheplapharm Arzneimittel. The same ATC class is registered in 18 of our 19 countries.

ATC J05AB14

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about valganciclovir hydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Valganciclovir is registered in 18 of 19 countries.

Countries holding a registration under ATC J05AB14 (valganciclovir), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
11 of them publish a price we can compare per daily dose

Search valganciclovir products by name

Valganciclovir · ATC J05AB14

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of valganciclovir costs, country by country.

Normalised to the WHO defined daily dose (0.9 g), the median price runs from $3.83 in United States to $35.27 in Italy — a ×9.2 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Valganciclovir · price per daily dose (0.9 g)

USD · FX 28 Sept 2026

IT Italy$35.27
CH Switzerland$35.18
FR France$22.39
US United States$3.83 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Valganciclovir Hydrochloride
Manufacturer: Cheplapharm Arzneimittel
Country: Belgium (BE)
ATC code: J05AB14
ATC class: Valganciclovir
Defined daily dose: 0.9 g, O
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 2

1 priced

be_apb
1663939
EUR 569.38
be_apb
0772467

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

283 interactions on record for valganciclovir.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check valganciclovir against other medicines How interaction checks work

Valganciclovir · interactions on record

283 records

8 severe
193 moderate
82 info

Most severe, free to view

CladribineL01BB04severe
TrospiumA03AB20moderate
Amphotericin BA07AA07moderate
TrospiumG04BD09moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Valganciclovir in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All valganciclovir products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

Austria · Valcyte, Valganciclovir +pharma
Bulgaria · Алваноцит, Валцит
Cyprus · Valcyte, Valganciclovir Accord
Czechia · Cytevix, Valcyte
Germany · Valcyte, Valganaxiro
Denmark · Valcyte, Valganciclovir "medical Valley"
Estonia · Valganciclovir Accord, Valganciclovir Sandoz
Spain · Valcyte, Valganciclovir Accord
Finland · Valcyte, Valganciclovir Accord
France · Rovalcyte, Valganciclovir Accord
United Kingdom (Northern Ireland) · Valcyte, Valganciclovir Accord Healthcare
Greece · Vagotrosin, Valcyte
Croatia · Alvanocyt, Valcyte
Hungary · Valcyte, Valdamin
Ireland · Valcyte, Valganciclovir Accord Healthcare
Iceland · Valcyte, Valganciclovir Medical Valley
Italy · Valcyte, Valganciclovir Accord
Lithuania · Valganciclovir Accord, Valganciclovir Sandoz
Luxembourg · Valcyte
Latvia · Valcyte, Valganciclovir Accord
Netherlands · Alvanocyt, Valcyte
Norway · Valcyte, Valganciclovir Accord
Poland · Ceglar, Valcyte
Portugal · Rovalcyte, Valganciclovir Accord
Romania · Valganciclovir Zentiva
Sweden · Valcyte, Valganciclovir Accord
Slovenia · Ganaxa, Valcyte
Slovakia · Valdamin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/a8bf5fe8-1b87-4548-8873-339696298d8a
GET /v1/drugs/a8bf5fe8-1b87-4548-8873-339696298d8a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Valcyte 450 mg",
  "name_fr": "Valcyte 450 mg",
  "name_nl": "Valcyte 450 mg",
  "amp_code": "SAM236941-00",
  "strengths": [
    "496.3000",
    "496.3000",
    "450.0000",
    "450.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Valganciclovir Hydrochloride",
    "Valganciclovir",
    "Polysorbate 80"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Valganciclovir",
  "authorisation_numbers": [
    "BE236941"
  ]
}

API reference MCP server Plans

See everything about valganciclovir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console